News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Lionsgate's film and TV library continues to generate steady licensing cash flow.
  • The company is cutting content spend, lowering cash burn and supporting near-term margins.
  • Recommended trade: buy entry $5.40, stop $4.60, target $7.20.
  • Microsoft's technicals show bullish momentum after a large gap up.
  • Microsoft trades at a premium with P/E near 27.7 and free cash flow around $60 billion.
  • Suggested swing trade aims to capture AI upside while limiting downside from uncertain AI capex.

Latest Articles

Cerebras: Positioning to Win the Inference Bottleneck

Cerebras: Positioning to Win the Inference Bottleneck

Cerebras (CBRS) is the highest-conviction way to play inference-focused AI infrastructure without owning only GPU incumbents. The company shows strong demand visibility (reported $25.4B in remaining performance obligations), high-profile partnerships and fresh data-center wins. At $203.50 today, I view CBRS as a long trade: enter $203.50, target $3…

Rocket Lab Unveils Germanium-Free Solar Cell, Shares Tick Up in Premarket

Rocket Lab Unveils Germanium-Free Solar Cell, Shares Tick Up in Premarket

Rocket Lab Corporation's stock rose modestly in premarket trading after the company introduced IMM Apex, a germanium-free solar cell designed for space use. The new cell delivers a Beginning of Life conversion efficiency of 31.5%, reduces cell mass by 40% versus conventional cells, and is positioned as a drop-in replacement to ease customer integra…

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit

Nutriband Inc. announced that its CEO, Gareth Sheridan, will participate in the Nasdaq LaB Biotech Summit. The company develops AVERSA™, an abuse-deterrent transdermal technology designed to prevent misuse of drugs such as fentanyl while maintaining patient access. Nutriband is focused on advancing its pipeline and leveraging its intellectual prope…

Virtuix to Highlight Accelerating Growth and Expanding Defense, Robotics and Healthcare Applications at H.C. Wainwright Conference

Virtuix to Highlight Accelerating Growth and Expanding Defense, Robotics and Healthcare Applications at H.C. Wainwright Conference

Virtuix Holdings Inc. announced that CEO Jan Goetgeluk will present at the H.C. Wainwright 28th Annual Global Investment Conference following quarterly revenue exceeding analyst estimates by over 50%. The company is expanding its Omni One platform into new high-growth sectors including defense, robotics, and healthcare, with notable partnerships an…

Urals Crude Surges Past $80 as Early-September Prices Reach Three-Month Peak

Urals Crude Surges Past $80 as Early-September Prices Reach Three-Month Peak

Free-on-board prices for Russian Urals crude tied to Baltic and Black Sea loadings have climbed above $80 per barrel for the first time since early June, marking the highest levels in roughly three months. The move follows a rise in global oil benchmarks toward $100 after fresh strikes in the Middle East raised questions about supply. The spot roub…

Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum

Silo Pharma to Highlight Patented Nose-to-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum

Silo Pharma announced its participation in the IPAC-RS 2026 Nasal Innovation Forum to highlight its innovative SPC-15 nose-to-brain drug delivery system aimed at treating PTSD. Preclinical data show promising stability and quality metrics. The company also advances other CNS-focused therapies and operates AI-driven platform QwikAgents, bridging bio…

Meta Shares Leap as Muse AI Agent Garners Bullish Analyst Backing

Meta Shares Leap as Muse AI Agent Garners Bullish Analyst Backing

Meta Platforms introduced Muse, a standalone personal AI agent, prompting widespread analyst enthusiasm that translated into roughly a 5% premarket rise in the company's shares. Analysts from Mizuho, KeyBanc and Morgan Stanley flagged Muse as evidence of progress on Meta’s heavy AI investments, highlighting its polish, breadth of capability and fre…

Buy ICE on Weakness: AI Panic Has Overshot the Fundamentals

Buy ICE on Weakness: AI Panic Has Overshot the Fundamentals

Intercontinental Exchange (ICE) has been marked down amid broad AI fears, but the company's cash generation, modest leverage, and durable franchise argue the selloff is overdone. We upgrade ICE to a buy for a mid-term swing trade, targeting $175 with a $146 stop. Catalysts include deal flow (MarketAxess tie-up), persistent data demand, and activist…

Raytech Holding Limited Announces Official Name Change to “Atlas Trinity Tech Limited” and New Ticker Symbol “ATTT” Effective September 10, 2026

Raytech Holding Limited Announces Official Name Change to “Atlas Trinity Tech Limited” and New Ticker Symbol “ATTT” Effective September 10, 2026

Raytech Holding Limited, a Hong Kong-based company specializing in personal care electrical appliances, announced it will change its official company name to Atlas Trinity Tech Limited and begin trading under the new Nasdaq ticker ATTT starting September 10, 2026. The change requires no action from current shareholders, and the company operations a…

Smithfield® Expands Commonwealth Clash Presenting Sponsorship with New Fan and Community Initiatives

Smithfield® Expands Commonwealth Clash Presenting Sponsorship with New Fan and Community Initiatives

Smithfield Foods announced it will continue as the presenting sponsor of the Commonwealth Clash rivalry between the University of Virginia and Virginia Tech for the 2026-27 season. The company introduces new fan engagement initiatives, including the 'Baconbassador' program, and community food drives supporting campus food assistance programs. This …

AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video

AIM ImmunoTech Highlights Scientific Rationale, Supportive Data and Continued Advancement of Ampligen® in Pancreatic Cancer in New CEO Corner Video

AIM ImmunoTech highlights ongoing Phase 2 DURIPANC study investigating Ampligen in combination with AstraZeneca's durvalumab for treating pancreatic cancer. The company emphasizes Ampligen's potential to reshape the tumor microenvironment and improve checkpoint inhibitor effectiveness, aiming to overcome pancreatic cancer's immunosuppressive challe…

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program

Omada Health announced an independent model by GlobalData estimating up to $11,142 in gross medical cost savings per member over five years due to its GLP-1 program. The virtual healthcare company's model highlights substantial reductions in disease onset, higher medication persistence, and increased cost savings across diverse demographic groups, …